Francisella tularensis is a small, gram-negative bacterium best known as the cause of tularemia, a serious zoonotic disease that affects humans and a wide range of wild and domestic animals. Exposure can occur through insect bites, contact with infected animals, ingestion of contaminated food or water, or inhalation of contaminated aerosols; the disease it produces is commonly called tularemia or rabbit fever. Because the organism is gram-negative and can be disseminated by inhalation, it has also attracted attention as a potential bioterrorism agent.
Characteristics
F. tularensis is a facultative intracellular coccobacillus that replicates within macrophages and other host cells. It is fastidious in the laboratory and often requires enriched media with cysteine for culture. The species contains several subspecies: the highly virulent Type A (subsp. tularensis) mainly found in North America, and the less virulent Type B (subsp. holarctica) found across the Northern Hemisphere. Because of its infectious dose and intracellular lifestyle, handling typically requires high-containment laboratory practices.
Transmission and Clinical Forms
Transmission routes are diverse. Common exposures include tick or deer fly bites, handling infected mammals (especially rabbits and rodents), ingestion of contaminated food or water, and inhalation of infectious aerosols or dust. Clinical presentations depend on route of entry and can include:
- Ulceroglandular: skin ulcer with regional lymphadenopathy (most common)
- Pneumonic: cough, chest pain and systemic illness after inhalation
- Oropharyngeal: sore throat and abdominal pain after ingestion
- Oculoglandular and typhoidal forms
Diagnosis, Treatment, and Prevention
Diagnosis is made by culture, serology, or molecular methods, but culture can pose a hazard to laboratory staff and is done under biosafety containment. Treatment typically uses effective antibiotics such as aminoglycosides (e.g., streptomycin or gentamicin), fluoroquinolones, or doxycycline, selected by severity and clinical context. There is no widely used licensed vaccine for the general public; an investigational live attenuated vaccine has been studied in at-risk groups. Control in nature focuses on reducing vector exposure and safe handling of wild animals.
History and Public Health Importance
The bacterium was recognized in the early 20th century in association with animal outbreaks and human cases. It remains an important zoonotic pathogen in parts of North America, Europe and Asia. Because of its high infectivity by aerosol and potential for severe disease, public health agencies classify F. tularensis as a high-priority pathogen and recommend specific precautions for laboratory diagnosis, clinical care, and outbreak control. For more general information see aerosol transmission risks and discussions of biodefense considerations.
Accurate recognition of clinical patterns, awareness of ecological risk factors (ticks, lagomorphs, rodents), and prompt antimicrobial therapy are central to limiting morbidity and preventing secondary spread. Ongoing surveillance, safe laboratory practice, and public education about vector avoidance remain key to controlling tularemia.